Arrowgrass Capital Partners (US)’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-866
Closed -$126K 204
2017
Q4
$126K Sell
866
-1,950
-69% -$278K ﹤0.01% 492
2017
Q3
$382K Sell
2,816
-11,440
-80% -$1.45M ﹤0.01% 532
2017
Q2
$1.78M Sell
14,256
-11,490
-45% -$1.37M 0.01% 484
2017
Q1
$3.06M Buy
25,746
+3,114
+14% +$375K 0.03% 386
2016
Q4
$2.61M Sell
22,632
-3,801
-14% -$423K 0.03% 335
2016
Q3
$2.76M Sell
26,433
-15,664
-37% -$1.64M 0.04% 272
2016
Q2
$4.1M Buy
+42,097
New +$3.98M 0.04% 209

Other funds holding CME

Arrowgrass Capital Partners (US)'s CME Position: Q1 2018 in Review

Arrowgrass Capital Partners (US) sold out of CME Group (CME) in Q1 2018, closing a stake of 866 shares — an estimated $126K sold.

Arrowgrass Capital Partners (US) first reported a position in CME in Q2 2016 and held it in 7 quarters. The position peaked at $4.1M in Q2 2016. 898 funds tracked by Wall St. Rank hold CME as of Q1 2018.

  • Arrowgrass Capital Partners (US) reported no remaining CME Group position as of Q1 2018 after selling out during the quarter.
  • Arrowgrass Capital Partners (US) sold 866 CME Group shares in Q1 2018, an estimated $126K.
  • Arrowgrass Capital Partners (US) first reported a position in CME Group in Q2 2016 and held it in 7 quarters.
  • Arrowgrass Capital Partners (US)'s CME Group position peaked at $4.1M in Q2 2016.
  • 898 funds tracked by Wall St. Rank held CME Group as of Q1 2018.

Based on Arrowgrass Capital Partners (US)'s 13F filing for Q1 2018, filed 15 May 2018.